Antipsychotic Drugs And CHC Assessments

Antipsychotic Drugs and CHC Assessments

If your relative is being given antipsychotic drugs for the treatment of Dementia or a psychological issue, this could influence their score in an NHS Continuing Healthcare assessment.

Currently, 750,000 people in the UK are diagnosed with Dementia. Around a third of those people are being treated with antipsychotic drugs. It is common knowledge that there are serious risks associated with such drugs including strokes and untimely death.

The vast majority of people diagnosed with Dementia experience behavioural and psychological symptoms. The symptoms have to be properly identified and managed to avoid a decline in health and attempt to reduce the person being prescribed potentially damaging antipsychotic drugs.

If your relative is being assessed for NHS Continuing Healthcare funding, it is vital that such needs are properly assessed whether or not they are receiving treatment with antipsychotic drugs. It may be important to mention signs of delirium, depression, pain or any developing psychological and emotional symptoms. There should be regular reviews of all symptoms and the accompanying interventions including ongoing safety monitoring to inform decisions about increasing/decreasing medication.

The above points are relevant in several of the care domains assessed in NHS Continuing Healthcare such as behaviour, cognition, communication and drugs. It will be useful if you’re putting together a summary of your relative’s care needs and risks during the process.

Anyone receiving treatment in the form of antipsychotic drugs requires careful management, as outlined above and as such, could increase the score they received in the domains. It is vital that the underlying needs are assessed, not the needs as they appear when a person is being fully managed.

If you require any advice about the NHS Continuing Healthcare process please get in touch or download our free guide here.